hindu.com | Feb. 2, 2024, 10:22 p.m.
Aurobindo arm formulation unit under U.S. FDA scanner
| Aurobindo
| U.s. fda
Read more
bqprime.com | Nov. 9, 2022, 2:53 p.m.
U.S. FDA Flags One Procedural Lapse At Laurus Labs' Facility
| U.s. fda flags
| Laurus labs
Read more
bqprime.com | Nov. 7, 2022, 4:10 p.m.
U.S. FDA Flags Procedural Lapses At Lupin’s Nagpur Facility
| U.s. fda flags
| Lupin
Read more
bqprime.com | Oct. 30, 2022, 7:13 p.m.
U.S. FDA Issues Form-483 With 5 Observations To Lupin's Nagpur Unit
| U.s. fda issues
| Lupin
Read more
bqprime.com | Oct. 1, 2022, 11:09 a.m.
Zydus Gets U.S. FDA Approval For Pulmonary Hypertension Drug
Read more
bqprime.com | Sept. 12, 2022, 2:21 p.m.
U.S. FDA Flags Three Procedural Lapses At Aurobindo Pharma’s Andhra Unit
| U.s. fda flags
| Aurobindo pharma
Read more
bqprime.com | Sept. 1, 2022, 11:40 a.m.
Biocon Biologics May See Delay In Key Launches On U.S. FDA Observations
| Biocon biologics
| Key
Read more
bqprime.com | July 27, 2022, 8:02 a.m.
Retail Investors Most At Risk From Drugmakers' Limited Disclosures On U.S. FDA Action
| Retail
| Risk from drugmakers
| U.s. fda
Read more
bqprime.com | July 7, 2022, 12:59 p.m.
Lupin Gets EIR From U.S. FDA For Somerset Facility
| Lupin
| Eir
| U.s.
| Somerset
Read more